Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Onconetix (ONCO) Shares Outstanding (Weighted Average) (2023 - 2025)

Onconetix (ONCO) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $9491.0 as the latest value for Q3 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 97.69% to $9491.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $9491.0, a 97.69% decrease, with the full-year FY2023 number at $427784.0, changed N/A from a year prior.
  • Shares Outstanding (Weighted Average) was $9491.0 for Q3 2024 at Onconetix, up from $6528.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.9 million in Q1 2023 to a low of $6528.0 in Q2 2024.